Investigation of Hepatitis B and Hepatitis C in Taiwan

This study has been completed.

Sponsor:

Information provided by:

National Taiwan University Hospital

ClinicalTrials.gov Identifier:

NCT00946010

First received: April 1, 2008

Last updated: January 20, 2011

Last verified: January 2011

History of Changes

Purpose

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Condition	Intervention
Hepatitis B Hepatitis C	Biological: blood sampling and abdominal sonography


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Cross-Sectional
Official Title:	Investigation of Hepatitis B and Hepatitis C in Taiwan

Resource links provided by NLM:

MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis B Hepatitis C

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:

genotype and DNA level or RNA level of HBV and HCV virus [ Time Frame: once during Mar. 2008- Jan. 2011 ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples With DNA

10ml blood was sampled and then serum was be retained.


Enrollment:	6228
Study Start Date:	April 2008
Study Completion Date:	January 2011
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan	Biological: blood sampling and abdominal sonography 10cc blood sampling and abdominal sonography Other Name: 10cc blood sampling and abdominal sonography

Detailed Description:

The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

Eligibility


Ages Eligible for Study:	23 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.

Criteria

Inclusion Criteria:

Born before 1985/01/01
HBV or HCV carriers

Exclusion Criteria:

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00946010

Locations


Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100

Sponsors and Collaborators

National Taiwan University Hospital

Investigators


Study Chair:	Jin-Chuan Sheu, M.D. P.H.D.	National Taiwan University Hospital

More Information


Responsible Party:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00946010 History of Changes
Other Study ID Numbers:	200801059R
Study First Received:	April 1, 2008
Last Updated:	January 20, 2011
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:


Hepatitis B Hepatitis C genotype	DNA level RNA level Taiwan

Additional relevant MeSH terms:


Hepatitis Hepatitis A Hepatitis C Hepatitis B Hepatitis, Viral, Human Liver Diseases Digestive System Diseases	Virus Diseases Enterovirus Infections Picornaviridae Infections RNA Virus Infections Flaviviridae Infections Hepadnaviridae Infections DNA Virus Infections

ClinicalTrials.gov processed this record on September 27, 2016

To Top